Glioma & Astrocytoma in Adults

We have experience in treating the most complex types of gliomas and astrocytomas. Our nationally known team of neurosurgeons, neuro-oncologists, radiologists, radiation oncologists, and neuropathologists partners to create a customized treatment plan for you.

Your team of specialists uses sophisticated diagnostic techniques, such as advanced MRI and precision molecular diagnosis, which determines the tumor’s specific molecular makeup.

Treatment may include targeted drugs, immunotherapy, and treatments provided through cutting-edge clinical trials. We also offer Gamma Knife® radiosurgery, a targeted treatment that provides an alternative to surgery and radiation therapy. Ultimately, we personalize a care plan just for you.

Clinical Trials and Research Studies

Phase 2

CDA Chi BMS A phase II trial of nivolumab ipilimumab and short course radiotherapy in newly diagnosed glioblastoma patients with unmethylated MGMT promoter BMS-936558 and BMS-734016

Phase 1/2

An Open-Label Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination with REGN2810 in Subjects with Newly-Diagnosed Glioblastoma (GBM)

Phase 1

ONC201 in Newly Diagnosed Diffuse Intrinsic Pontine Glioma and Recurrent/Refractory Pediatric H3 K27M Gliomas

Phase 4

APEC1621SC: NCI-COG PEDIATRIC MATCH (MOLECULAR ANALYSIS FOR THERAPY CHOICE) SCREENING PROTOCOL